Park Ha Biological Technology
BYAH · NASDAQ
$2.32−$0.04 (−1.69%)TodayMarket closed ·
Prev close $2.36
Key indicators
BYAH profitability and balance sheet ratios
EPS -$2.62 in Apr 2026, against -$295.09 a year earlier.
| Period | EPS |
|---|---|
| Oct 2023 | $0.0325 |
| Apr 2024 | $0.0019 |
| Oct 2024 | $0.9571 |
| Apr 2025 | -$295.09 |
| Oct 2025 | -$56.61 |
| Apr 2026 | -$2.62 |
Income statement
No financial statements are reported for Park Ha Biological Technology.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Apr 2025 | Oct 2025 | Apr 2026 |
|---|---|---|---|
| Total assets | $5.8M | $6.0M | $7.5M |
| Total liabilities | $1.6M | $2.0M | $2.1M |
| Shareholder equity | $4.3M | $4.0M | $5.4M |
| Cash and short-term investments | $1.4M | $3.8M | $5.7M |
| Total debt | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.